Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1993 Nov;37(11):2422-6.
doi: 10.1128/AAC.37.11.2422.

Protective effect of picolinic acid on mice intracerebrally infected with lethal doses of Candida albicans

Affiliations

Protective effect of picolinic acid on mice intracerebrally infected with lethal doses of Candida albicans

E Blasi et al. Antimicrob Agents Chemother. 1993 Nov.

Abstract

We have studied the effects of picolinic acid (PLA), a product of tryptophan degradation, on mouse susceptibility to intracerebral infection with Candida albicans. We show that intraperitoneal administration of PLA significantly enhances the median survival time of mice inoculated with the lethal challenge. Furthermore, intracerebral administration of this agent induces a protective state against the local lethal infection, the phenomenon depending upon the administration schedule and doses of PLA employed. According to survival data, yeast growth in the brain as well as yeast colonization of the kidneys are drastically reduced in PLA-treated mice compared with those for untreated controls. Northern (RNA) blot analysis of brain tissues demonstrates that mRNA levels specific for tumor necrosis factor and interleukin 1 are augmented and induced, respectively, after inoculation of PLA. These results indicate that PLA has a protective effect likely involving elicitation of a cytokine response in vivo against fungal infections.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Science. 1983 Jan 21;219(4582):316-8 - PubMed
    1. Mol Cell Biol. 1983 May;3(5):787-95 - PubMed
    1. Am J Med. 1984 Jan;76(1):101-8 - PubMed
    1. J Immunopharmacol. 1984;6(4):291-304 - PubMed
    1. Proc Natl Acad Sci U S A. 1986 Mar;83(6):1670-4 - PubMed

Publication types

MeSH terms